Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
US House Of Representatives Successfully Marked Up Bureaucracy-Cutting Q1/Q2 Generic Drug Bill
As The ‘Red Tape’ Biosimilar Interchangeability Bill Is Reintroduced
Sep 23 2025
•
By
Urtė Fultinavičiūtė
• Source: Shutterstock
More from Regulation
More from Policy & Regulation
